Stockreport

Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify’s iPSC- and ESC-derived regulatory T cells

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF CAMBRIDGE, England & BRISBANE, Calif.--(BUSINESS WIRE)--Mogrify Ltd (Mogrify®), a UK company aiming to transform the development of cell therapies by the systematic [Read more]